Related Experiment Video
Updated: Jun 28, 2026

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Multiple sclerosis in childhood: clinical and radiological features
Michael B Forrester1, Lee Coleman, Andrew J Kornberg
1Department of Neurology Royal Children's Hospital, Melbourne, Australia.
Journal of Child Neurology
|October 23, 2008
Summary
Early onset multiple sclerosis in children presents with optic neuritis and pyramidal dysfunction. Treatment with immunomodulatory therapy reduced relapse rates, indicating its efficacy in managing pediatric multiple sclerosis.
Area of Science:
- Neurology
- Pediatrics
- Immunology
Background:
- Early onset multiple sclerosis (EOMS) is a rare demyelinating disease in children.
- Understanding EOMS clinical and neuroimaging features is crucial for early diagnosis and management.
- Comparing EOMS with acute demyelinating encephalomyelitis (ADEM) and adult multiple sclerosis (MS) aids in differential diagnosis.
Purpose of the Study:
- To analyze the clinical and neuro-radiological characteristics of pediatric multiple sclerosis.
- To compare these features with ADEM and adult MS.
- To evaluate the efficacy of immunomodulatory therapy in EOMS.
Main Methods:
- Retrospective analysis of medical records and cerebral imaging in 30 children with EOMS.
- Comparison of clinical and radiological findings with ADEM and adult MS cohorts.
- Assessment of Expanded Disability Status Scale (EDSS) scores and relapse rates.
- Evaluation of treatment outcomes with immunomodulatory therapies.
Main Results:
- The female to male ratio in EOMS was 1.3 before age 12, increasing to 4.3 after age 12.
- Common presenting symptoms included optic neuritis and pyramidal dysfunction.
- Radiological findings revealed periventricular lesions, corpus callosal demyelination, gadolinium enhancement, and Dawson's fingers.
- Median relapse rate was 1.2 per patient-year, with EDSS score increasing by 0.7 per relapse.
- Immunomodulatory therapy (Interferon beta 1a, Interferon beta 1b, Glatiramer acetate) was initiated in 10 patients, showing minimal side effects and reduced relapse rates.
Conclusions:
- EOMS exhibits distinct clinical and radiological patterns in children.
- Early diagnosis and intervention with immunomodulatory therapies can effectively manage EOMS, reducing relapse rates and disability progression.
- Further research is warranted to elucidate long-term outcomes and optimal treatment strategies for pediatric MS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
